Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

JAK2 -mutant clonal hematopoiesis is associated with venous thromboembolism

Rebecca L. Zon, Aswin Sekar, Katharine Clapham, Ohad Oren, Abhishek Niroula, Alexander G. Bick, Christopher J. Gibson, Gabriel Griffin, Md Mesbah Uddin, Donna Neuberg, Pradeep Natarajan, Benjamin L. Ebert

Blood (2024) 144 (20): 2149–2154.

https://doi.org/10.1182/blood.2024024187

Published: 2024

Includes: Supplemental data

Journal Articles

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy

Blood (2023) 142 (24): 2079–2091.

https://doi.org/10.1182/blood.2023020331

Published: 2023

Includes: Supplemental data

Journal Articles

Specific Clonal Mutations Are Predictive of Therapy-Related Myeloid Neoplasms (tMN) after Autologous Peripheral Blood Stem Cell Transplantation (aPBSCT) for Lymphoma

Smita Bhatia, Chengcheng Yan, Melissa A Richard, Jianbo He, Alysia Bosworth, David Crossman, Purnima Singh, Lindsey Hageman, Saro H. Armenian, Julie M. Vose, Daniel J. Weisdorf, Yutaka Yasui, Benjamin L. Ebert, Christopher J. Gibson, Stephen J Forman, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 295–297.

https://doi.org/10.1182/blood-2022-165604

Published: 2022

Journal Articles

Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis

Lachelle D. Weeks, Abhishek Niroula, Donna S. Neuberg, Waihay J. Wong, R. Coleman Lindsley, Marlise R. Luskin, Nancy Berliner, Richard M. Stone, Daniel J DeAngelo, Robert J Soiffer, Md Mesbah Uddin, Christopher J. Gibson, Alexander G. Bick, Gabriel K. Griffin, Siddhartha Jaiswal, Luca Malcovati, Pradeep Natarajan, Benjamin L. Ebert

Blood (2022) 140 (Supplement 1): 2229–2231.

https://doi.org/10.1182/blood-2022-158960

Published: 2022

Journal Articles

Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study

Blood (2022) 140 (Supplement 1): 917–919.

https://doi.org/10.1182/blood-2022-157611

Published: 2022

Journal Articles

Prevalence of Clonal Hematopoiesis of Indeterminate Potential in Patients with Monoclonal B-Cell Lymphocytosis Compared to Untreated Chronic Lymphocytic Leukemia

Anisha V. Patel, Abirami Vijenthira, Aswin Sekar, Christopher J. Gibson, Stephen P. Martindale, Rayan Fardoun, Svitlana Tyekucheva, Stacey M. Fernandes, Binyamin A. Knisbacher, Cynthia K. Hahn, Gad Getz, Catherine J. Wu, Matthew S. Davids, Jennifer R. Brown

Blood (2022) 140 (Supplement 1): 7038–7040.

https://doi.org/10.1182/blood-2022-162707

Published: 2022

Journal Articles

Survival of Patients with Multiple Myeloma Diagnosed with Second Primary Malignancies: An ASCO Cancerlinq Analysis

John D Cooper, Jennifer A Thornton, Steven J Gibson, Kevin Pham, Kevin Sunderland, Christin B DeStefano

Blood (2022) 140 (Supplement 1): 10039–10040.

https://doi.org/10.1182/blood-2022-170859

Published: 2022

Journal Articles

Association of Clonal Hematopoiesis of Indeterminate Potential with Time to First Treatment, Incidence of Richter's Syndrome, and Overall Survival in Patients with Chronic Lymphocytic Leukemia

Abi Vijenthira, Aswin Sekar, Christopher J. Gibson, Stephen P. Martindale, Rayan Fardoun, Svitlana Tyekucheva, Yue Ren, Stacey M. Fernandes, Binyamin A. Knisbacher, Cynthia K. Hahn, Gad Getz, Catherine J. Wu, Matthew S. Davids, Jennifer R. Brown

Blood (2022) 140 (Supplement 1): 9868–9870.

https://doi.org/10.1182/blood-2022-163273

Published: 2022

Journal Articles

Secondary Primary Malignancies (SPMs) in Adolescent and Young Adults (AYAs) with Multiple Myeloma (MM): An ASCO Cancerlinq Analysis

Steven J Gibson, John D Cooper, Jennifer A Thornton, Kevin Pham, Kevin Sunderland, Christin B DeStefano

Blood (2022) 140 (Supplement 1): 7168–7169.

https://doi.org/10.1182/blood-2022-169308

Published: 2022

Journal Articles

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19

Blood (2022) 140 (18): 1993–1997.

https://doi.org/10.1182/blood.2022018052

Published: 2022

Includes: Supplemental data

Journal Articles

TET2 -mutant clonal hematopoiesis and risk of gout

Blood (2022) 140 (10): 1094–1103.

https://doi.org/10.1182/blood.2022015384

Published: 2022

Includes: Supplemental data

Journal Articles

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Blood (2022) 139 (24): 3546–3557.

https://doi.org/10.1182/blood.2021014520

Published: 2022

Includes: Supplemental data

Journal Articles

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Peter G. Miller, Dandi Qiao, Joselyn Rojas-Quintero, Michael C. Honigberg, Adam S. Sperling, Christopher J. Gibson, Alexander G. Bick, Abhishek Niroula, Marie E. McConkey, Brittany Sandoval, Brian C. Miller, Weiwei Shi, Kaushik Viswanathan, Matthew Leventhal, Lillian Werner, Matthew Moll, Brian E. Cade, R. Graham Barr, Adolfo Correa, L. Adrienne Cupples, Sina A. Gharib, Deepti Jain, Stephanie M. Gogarten, Leslie A. Lange, Stephanie J. London, Ani Manichaikul, George T. O’Connor, Elizabeth C. Oelsner, Susan Redline, Stephen S. Rich, Jerome I. Rotter, Vasan Ramachandran, Bing Yu, Lynette Sholl, Donna Neuberg, Siddhartha Jaiswal, Bruce D. Levy, Caroline A. Owen, Pradeep Natarajan, Edwin K. Silverman, Peter van Galen, Yohannes Tesfaigzi, Michael H. Cho, Benjamin L. Ebert, for the COPDGene Study Investigators, National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine Consortium

Blood (2022) 139 (3): 357–368.

https://doi.org/10.1182/blood.2021013531

Published: 2022

Includes: Supplemental data

Journal Articles

Clonal Hematopoiesis Is Frequent and Associated with Inferior Survival Irrespective of Transplantation Strategy in Patients with Newly Diagnosed Multiple Myeloma

Adam S. Sperling, Robert Redd, Christopher J. Gibson, Peter G. Miller, Jill Corre, Philippe Moreau, Donna S. Neuberg, Mehmet K. Samur, Benjamin L. Ebert, Herve Avet-Loiseau, Nikhil C. Munshi

Blood (2021) 138 (Supplement 1): 1127.

https://doi.org/10.1182/blood-2021-148050

Published: 2021

Journal Articles

Blinatumomab Is Cost-Effective Compared to Standard Chemotherapy for Children with High Risk Relapses of Acute Lymphoblastic Leukemia: A Cost-Effectiveness Analysis Using Population-Based Healthcare Data

Petros Pechlivanoglou, Linda Luu, Qing Li, Paul J. Gibson, Uma H. Athale, Mylene Bassal, Vicky R. Breakey, Serina Patel, Jason Pole, Rinku Sutradhar, Laura Wheaton, Nicole Mittmann, Sumit Gupta

Blood (2021) 138 (Supplement 1): 565.

https://doi.org/10.1182/blood-2021-154193

Published: 2021

Journal Articles

The Association between Clonal Hematopoiesis and Gout

Mridul Agrawal, Abhishek Niroula, Pierre Cunin, Marie McConkey, Peter G. Kim, Waihay J. Wong, Lachelle D. Weeks, Amy E. Lin, Peter G. Miller, Christopher J. Gibson, Aswin Sekar, Donna S. Neuberg, Alexander G. Bick, Pradeep Natarajan, Peter A. Nigrovic, Deepak A. Rao, Benjamin L. Ebert

Blood (2021) 138 (Supplement 1): 595.

https://doi.org/10.1182/blood-2021-153639

Published: 2021

Journal Articles

Rates and Predictors of Visits to Primary Care Physicians during and after Treatment of Childhood Acute Lymphoblastic Leukemia: A Population-Based Cohort Study

Vicky R. Breakey, Paul Nathan, Serina Patel, Laura Wheaton, Qing Li, Rinku Sutradhar, Mylene Bassal, Paul J. Gibson, Jason Pole, Uma H. Athale, Sumit Gupta

Blood (2021) 138 (Supplement 1): 839.

https://doi.org/10.1182/blood-2021-147326

Published: 2021

Journal Articles

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Blood (2021) 138 (10): 898–911.

https://doi.org/10.1182/blood.2021011075

Published: 2021

Includes: Supplemental data

Journal Articles

Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis

Blood (2020) 136 (26): 3051–3055.

https://doi.org/10.1182/blood.2020008206

Published: 2020

Includes: Supplemental data

Journal Articles

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Mikko Myllymäki, Robert Redd, Christopher R. Reilly, Wael Saber, Stephen R. Spellman, Christopher J. Gibson, Zhen-Huan Hu, Tao Wang, Esther H. Orr, Jaclyn G. Grenier, Maxine M. Chen, David P. Steensma, Corey Cutler, Immaculata De Vivo, Joseph H. Antin, Donna Neuberg, Suneet Agarwal, R. Coleman Lindsley

Blood (2020) 136 (26): 3070–3081.

https://doi.org/10.1182/blood.2020005397

Published: 2020

Includes: Supplemental data

NARROW

JAK2 -mutant clonal hematopoiesis is associated with venous thromboembolism

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy

Specific Clonal Mutations Are Predictive of Therapy-Related Myeloid Neoplasms (tMN) after Autologous Peripheral Blood Stem Cell Transplantation (aPBSCT) for Lymphoma

Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis

Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study

Prevalence of Clonal Hematopoiesis of Indeterminate Potential in Patients with Monoclonal B-Cell Lymphocytosis Compared to Untreated Chronic Lymphocytic Leukemia

Survival of Patients with Multiple Myeloma Diagnosed with Second Primary Malignancies: An ASCO Cancerlinq Analysis

Association of Clonal Hematopoiesis of Indeterminate Potential with Time to First Treatment, Incidence of Richter's Syndrome, and Overall Survival in Patients with Chronic Lymphocytic Leukemia

Secondary Primary Malignancies (SPMs) in Adolescent and Young Adults (AYAs) with Multiple Myeloma (MM): An ASCO Cancerlinq Analysis

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19

TET2 -mutant clonal hematopoiesis and risk of gout

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Clonal Hematopoiesis Is Frequent and Associated with Inferior Survival Irrespective of Transplantation Strategy in Patients with Newly Diagnosed Multiple Myeloma

Blinatumomab Is Cost-Effective Compared to Standard Chemotherapy for Children with High Risk Relapses of Acute Lymphoblastic Leukemia: A Cost-Effectiveness Analysis Using Population-Based Healthcare Data

The Association between Clonal Hematopoiesis and Gout

Rates and Predictors of Visits to Primary Care Physicians during and after Treatment of Childhood Acute Lymphoblastic Leukemia: A Population-Based Cohort Study

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only